Effectiveness of pentavalent rotavirus vaccine against severe disease

Pediatrics

Volumn 128, Issue 2, 2011, Pages

  Staat, Mary Allen ^a   Payne, Daniel C ^b   Donauer, Stephanie ^a   Weinberg, Geoffrey A ^c   Edwards, Kathryn M ^c   Szilagyi, Peter G ^c   Griffin, Marie R ^d   Hall, Caroline B ^d   Curns, Aaron T ^b   Gentsch, Jon R ^b   Salisbury, Shelia ^a   Fairbrother, Gerry ^a   Parashar, Umesh D ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acute gastroenteritis; Population based surveillance; Rotavirus; RV5; Vaccine effectiveness; Vaccine impact

Indexed keywords

ROTAVIRUS VACCINE;

ACUTE GASTROENTERITIS; AGE DISTRIBUTION; ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DISEASE SURVEILLANCE; DRUG EFFICACY; FEMALE; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; ROTAVIRUS; ROTAVIRUS INFECTION; TREATMENT OUTCOME; VIRUS STRAIN; VIRUS TYPING;

CASE-CONTROL STUDIES; CHILD, PRESCHOOL; FEMALE; GASTROENTERITIS; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VACCINES, ATTENUATED;

EID: 79960805267     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2010-3722     Document Type: Article

References (27)

1. Parashar UD, Holman RC, Clarke MJ, Bresee JS, Glass RI. Hospitalizations associated with rotavirus diarrhea in the United States, 1993 through 1995: surveillance based on the new ICD-9-CM rotavirus-specific diagnostic code. J Infect Dis. 1998; 177(1):13-17 (Pubitemid 28030428)
2. Charles MD, Holman RC, Curns AT, et al. Hospitalizations associated with rotavirus gastroenteritis in the United States, 1993-2002. Pediatr Infect Dis J. 2006;25(6):489-493 (Pubitemid 43863357)
3. Malek MA, Curns AT, Holman RC, et al. Diarrhea- and rotavirus-associated hospitalizations among children less than 5 years of age: United States, 1997 and 2000. Pediatrics. 2006;117(6):1887-1892 (Pubitemid 46071230)
4. Fischer TK, Viboud C, Parashar U, et al. Hospitalization and deaths from diarrhea due to rotavirus among children <5 years of age in the United States, 1993-2003. J Infect Dis. 2007;195(8):1117-1125 (Pubitemid 46543442)
5. Tucker AW, Haddix AC, Bresee JS, et al. Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA. 1998;279(17):1371- 1376
6. Widdowson M-A, Meltzer MI, Zhang X, et al. Cost-effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics. 2007;119(4):684-697 (Pubitemid 46556667)
7. Centers for Disease Control and Prevention. Prevention of rotavirus gastroenteritis among infants and children. MMWR Recomm Rep. 2006; 55(RR-12):1-13
8. American Academy of Pediatrics Committee on Infectious Diseases. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine. Committee on Infectious Diseases. Pediatrics. 2007:119(1):171-182
9. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354(1):23-33 (Pubitemid 43048948)
10. Clemens J, Brenner R, Rao M, et al. Evaluating new vaccines for developing countries: efficacy or effectiveness? JAMA. 1996;275(5):390-397 (Pubitemid 26046004)
11. Orenstein WA, Bernier RH, Dondero TJ, et al. Field evaluation of vaccine efficacy. Bull World Health Organ. 1985;63(6):1055-1068 (Pubitemid 16055438)
12. Chen RT, Orenstein W. Epidemiologic methods in immunization programs. Epidemiol Rev. 1996;18(2):99-117 (Pubitemid 27082083)
13. Comstock GW. Evaluating vaccination effectiveness and vaccine efficacy by means of case-control studies. Epidemiol Rev. 1994;16(1):77-89 (Pubitemid 24217786)
14. Payne DC, Staat MA, Edwards KM, et al. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics. 2008;122(6):1235-1243
15. Payne DC, Szilagyi PG, Staat MA, et al. Secular variation in US rotavirus disease rates and serotype-implications for assessing the rotavirus vaccination program. [published correction appears in Pediatr Infect Dis J. 2010;29(3):287-288]. Pediatr Infect Dis J. 2009;28(11):948-953
16. Gouvea V, Glass RI, Woods P, et al. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol. 1990;28(2):276-282 (Pubitemid 20050935)
17. Gentsch JR, Glass RI, Woods P, et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol. 1992;30(6):1365-1373
18. Griffin DD, Nakagomi T, Hoshino Y, et al. Characterization of nontypeable rotavirus strains from the United States: Identification of a new rotavirus reassortant P2A[6], G12) and rare P3[9] strains related to bovine rotaviruses. Virology. 2002;294(2):256-269 (Pubitemid 34920524)
19. Das BK, Gentsch JR, Cicirello HG, et al. Characterization of rotavirus strains from newborns in New Delhi, India. J Clin Microbiol. 1994;32(7):1820-1822 (Pubitemid 24189584)
20. Iwane MK, Edwards KM, Szilagyi PG, et al. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics. 2004;113(6):1758-1764 (Pubitemid 38697988)
21. Poehling KA, Edwards KM, Weinberg GA, et al. The underrecognized burden of influenza in young children. N Engl J Med. 2006;355(1):21-30
22. Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360(6):588-598
23. Boom JA, Tate JE, Sahni LC, et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics. 2010;125(2). Available at: www.pediatrics.org/cgi/content/full/125/2/e199
24. Boom JA, Tate JE, Sahni LC, et al. Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban US pediatric hospital. Pediatr Infect Dis J. 2010;29(12):1133-1135
25. Wang FT, Mast C, Glass RJ, Loughlin J, Seeger JD. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States. Pediatrics. 2010; 125(2). Available at: www.pediatrics.org/cgi/content/ full/125/2/e208
26. Cortese MM, Parashar UD; Centers for Disease Control and Prevention (CDC). Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2009;58(RR-2):1-25
27. Committee on Infectious Diseases; American Academy of Pediatrics. Prevention of rotavirus disease: updated guidelines for use of rotavirus vaccine. Pediatrics. 2009;123(5):1412-1420